Krystal Biotech Inc
Veridion Score
Composite trend over time
Why is KRYS moving today?
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for KRYS.
KRYS insider activity
Krystal Biotech Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$110.5M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | 2026-06-04 | Krishnan Suma | Insider | sell | $311.65 | 240 | 1,378,155 | $75K | SEC Form 4 |
| 2026-06-05 | 2026-06-04 | Krishnan Suma | Insider | sell | $310.94 | 2,039 | 1,378,395 | $634K | SEC Form 4 |
| 2026-06-05 | 2026-06-04 | Krishnan Suma | Insider | sell | $309.95 | 2,801 | 1,380,434 | $868K | SEC Form 4 |
| 2026-06-05 | 2026-06-04 | Krishnan Suma | Insider | sell | $308.89 | 3,803 | 1,383,235 | $1.2M | SEC Form 4 |
| 2026-06-05 | 2026-06-04 | Krishnan Suma | Insider | sell | $307.81 | 12,729 | 1,387,038 | $3.9M | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 147 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moKRYS contract awards, year to date.
Public federal awards linked to this ticker.
KRYS lobbying filings, year to date.
Registered lobbying filings matched to Krystal Biotech Inc.